Browse Tag

CSL

CSL Limited (ASX: CSL) pre‑open brief for 17 November 2025: Buy‑back in full swing, Seqirus spin‑off delayed, guidance cut — here’s what matters

CSL Share Price Update: Buy‑Back Acceleration and US$1.5 Billion US Expansion Shape Outlook on 21 November 2025

MELBOURNE / SYDNEY – 21 November 2025 – CSL Limited (ASX: CSL), the Australian biopharmaceutical giant and long‑time ASX 20 heavyweight, entered Friday’s trade with two dominant storylines: a fresh on‑market share buy‑back update lodged with the ASX this morning, and the

21 November 2025

CSL’s Vaccine Shock: Stock Plunges to 7-Year Low Amid Shareholder Revolt

Vaccine Slump Triggers Profit Downgrade and 7-Year Share Low CSL – Australia’s fourth-largest public company – stunned the market by cutting its profit outlook and delaying a major spinoff due to a steep and unexpected decline in flu vaccinations in the United

28 October 2025

Business News · Health Industry · NYSE:CSLLY · Shareholder Activism · Stock Market · Vaccines

Asia Stocks Rally as Gold Smashes Record Highs and IPO Frenzy Grips Markets

Wall Street Hits Record Highs as ASX Slumps – Gold Crashes, CSL Plunges 15% in Shock Divergence

ASX Sinks Amid Global Cheer Global markets are riding high on hopes of a U.S.–China trade truce and easier monetary policy, but Australia’s share market didn’t get the memo. On Tuesday (Oct 28), the S&P/ASX 200 index closed down 0.5%, surrendering about 43

28 October 2025

ASX · Gold Prices · Investment News · Stock Market · Wall Street

Go toTop